Peter Reiss
Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years
Schoepf I, Bernasconi E, Cavassini M, Buvelot H, Arribas J, Kouyos R, Fellay J, Günthard H, Tarr P, Seneghini M, Marzolini C, Thurnheer C, Thorball C, Ledergerber B, Kootstra N, Reiss P, Raffenberg M, Engel T, Braun D, Hasse B, Swiss HIV Cohort Study. Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years. J Infect Dis 2021
Dec 15, 2021Telomere Length Declines In Persons Living With HIV Before Antiretroviral Therapy Start But Not After Viral Suppression: A Longitudinal Study Over >17 Years
Dec 15, 2021J Infect Dis 2021
Schoepf Isabella C, Bernasconi Enos, Cavassini Matthias, Buvelot Hélène, Arribas José R, Kouyos Roger D, Fellay Jacques, Günthard Huldrych F, Tarr Philip E, Seneghini Marco, Marzolini Catia, Thurnheer Christine, Thorball Christian W, Ledergerber Bruno, Kootstra Neeltje A, Reiss Peter, Raffenberg Marieke, Engel Tanja, Braun Dominique L, Hasse Barbara, Swiss HIV Cohort Study
Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Schoepf I, Tarr P, Fellay J, Günthard H, Kouyos R, Buvelot H, Cavassini M, Bernasconi E, Seneghini M, Thurnheer C, Marzolini C, Hasse B, Reiss P, Kootstra N, Raffenberg M, Engel T, Ledergerber B, Thorball C, Swiss HIV Cohort Study. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study. Clin Infect Dis 2021; 73:1597-1604.
Jan 2, 2021Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study
Jan 2, 2021Clin Infect Dis 2021; 73:1597-1604
Schoepf Isabella C, Tarr Philip E, Fellay Jacques, Günthard Huldrych F, Kouyos Roger, Buvelot Hélène, Cavassini Matthias, Bernasconi Enos, Seneghini Marco, Thurnheer Christine, Marzolini Catia, Hasse Barbara, Reiss Peter, Kootstra Neeltje A, Raffenberg Marieke, Engel Tanja, Ledergerber Bruno, Thorball Christian W, Swiss HIV Cohort Study
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagliola D, Schmid P, Calmy A. Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz500.
Dec 8, 2019Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Dec 8, 2019Open Forum Infect Dis 2019; 6:ofz500
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagliola Dominique, Schmid Patrick, Calmy Alexandra
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Olearo F, D'arminio Monforte A, Zazzi M, Rossetti B, Neau D, Bellecave P, Rijnders B, Reiss P, Wit F, Kouyos R, Boeni J, Bernasconi E, Günthard H, Nguyen H, Bonnet F, Yerly S, Wandeler G, Stoeckle M, Cavassini M, Scherrer A, Costagiola D, Schmid P, Calmy A. Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients. Open Forum Infect Dis 2019; 6:ofz330.
Jul 12, 2019Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients
Jul 12, 2019Open Forum Infect Dis 2019; 6:ofz330
Olearo Flaminia, D'arminio Monforte Antonella, Zazzi Maurizio, Rossetti Barbara, Neau Didier, Bellecave Pantxika, Rijnders Bart, Reiss Peter, Wit Ferdinand, Kouyos Roger, Boeni Jürg, Bernasconi Enos, Günthard Huldrych F, Nguyen Huyen, Bonnet Fabrice, Yerly Sabine, Wandeler Gilles, Stoeckle Marcel, Cavassini Matthias, Scherrer Alexandra, Costagiola Dominique, Schmid Patrick, Calmy Alexandra